drugset / Trial / NCT00412035

Botox Injection for Lower Extremity Lengthening and Deformity Correction Surgery

NCT00412035

Phase 3 Completed 125 enrolled Shriners Hospitals for Children
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this six site multi-center study is to determine if BTX-A can alleviate the post-operative pain and improve the functional and quality of life outcomes of children with limb length discrepancy or angular deformity undergoing limb lengthening or deformity correction.

Timeline

Start
2007-01
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 10 iu/kg Intramuscular